Overview

This trial is active, not recruiting.

Conditions atrial fibrillation, stroke
Treatment ecg screening for atrial fibrillation
Sponsor Karolinska University Hospital
Start date March 2012
End date March 2019
Trial size 7173 participants
Trial identifier NCT01593553, Strokestop

Summary

The purpose of this study is to determine whether screening for atrial fibrillation by intermittent ECG recording and initiation of anticoagulation treatment among high risk individuals is cost-effective and can lower the incidence of stroke.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Allocation randomized
Intervention model parallel assignment
Masking open label
Primary purpose prevention
Arm
(Experimental)
ecg screening for atrial fibrillation
ECG screening for atrial fibrillation with intermittent ECG recording for 14 days. Introduction of anticoagulants in the case of atrial fibrillation.
(No Intervention)

Primary Outcomes

Measure
Reduced incidence of stroke among 75 year old subjects.
time frame: Five years. Interim analysis after 3 years.

Secondary Outcomes

Measure
Cost effectivity
time frame: Five years

Eligibility Criteria

Male or female participants from 75 years up to 76 years old.

Inclusion Criteria: - Men and women 75-76 years of age living in the region of Stockholm or Halland Exclusion Criteria: - Not fulfilling the inclusion criteria

Additional Information

Official title Systematic ECG Screening for Atrial Fibrillation Among 75 Year Old Subjects in the Region of Stockholm and Halland, Sweden.
Trial information was received from ClinicalTrials.gov and was last updated in August 2016.
Information provided to ClinicalTrials.gov by Karolinska University Hospital.